IMPACT OF DIABETES ON EARLY AND MIDTERM OUTCOME OF CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION.
- Departement of cardiology military hospital Rabat.
- Departement of heart surgery military hospital Rabat.
- University Mohamed V Morocco.
8 Downloads
71 Views
Abstract
Background and aim of the study: diabetes mellitus (dm) is an independant cardiovascular risk factor. It increases both the severity and the risk of coronary artery disease.
The present study investigated patient characteristics, early postoperative outcome, and mid-term survival in dm and non-dm patients with left ventricular dysfunction after isolated coronary artery bypass grafting.
Methods: we performed a retrospective study that included 112 patients (61 without m and 51 with) with low left ventricular ejection fraction (≤45%) undergoing coronary artery bypass graft surgery (CABG) from 1994 to 2012 with a mean follow-up time of 48?8 months.
Results: dm patients differed from those without dm in terms of previous history of htn, mi and stroke. Diabetics were at higher risk for immediate postoperative sternal wound infection, and renal failure.
30 days operative mortality after CABG was 6.5% in non diabetic patients versus 5,8% in diabetic patients. However, 4 year mortality was 26,4% and 23,3% respectively.
Conclusion: dm is associated with increased early postoperative (renal failure and sternal infection) but doesn?t impact operative mortality and midterm survival after coronary artery bypass graft surgery among patients with left ventricular dysfunction
Keywords
Article Analytics
References
- Moutakiallah Y, Benzaghmout K, Aithoussa M, et al. La chirurgie coronaire sous circulation extra-corporelle chez le patient diab?tique. The Pan African Medical Journal. 2014;17:199. doi:10.11604/pamj.2014.17.199.2379.
- Chiariello M. et coll. Silent myocardial ischemia in patients with diabetes mel- litus. Circulation 1996 ; 93 : 2089-91.
- Gum P.A. et coll. Bypass surgery versus coronary angioplasty for revasculari- zation of treated diabetic patients. Circulation 1997 ; 96 (suppl. II) : II 7-II 10.
- Weintraub WS, Grau-Sepulveda MV, Weiss JM et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012;366(16):1467-76.
- Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; Nov 4
- Eric J. Velazquez et all. Coronary Artery Bypass Surgery in patients with Left Ventricular Dysfunction. The N Engl J Med? 2011?; 364?: 1607-16
- John Alfred Carr et all. Long term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg 2002?; 74?: 1531-6
- Abboud C et al. Risk factor for mediastinitis after cardiac surgery. ATS 2004;77(2):676?83.
- S? M, Soares E, Santoss? C et al - Risk factors for mediastinitis after coronary artery bypass grafting surgery Rev Bras Cir Cardiovasc 2011;26.1:27-35.
- Li J et al. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Tex Heart Inst J 2006;33(4)445-1
- Furnary A et al. Effect of hyperglycemia and continuous intravenous insulin infusion on outcomes of cardiac surgical procedures. Endocr Pract 2004;10(S2):21-33.
- Ledur P, Almeida L, Pellanda LC et al. Predictors of infection in post-coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011;26(2):190-6.
- Toumpoulis I, C, Derose J et al. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest. 2005;127(2):464-71.
- Farsky PS et al. Risk factors for sternal wound infections and application of the STS score in coronary artery bypass graft surgery Rev Bras Cir Cardiovasc 2011;26(4):624-9.
- Abboud CS, Wey SB, Baltar VT et al. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004;77(2):676-83.
- Ledur P, Almeida L, Pellanda LC, Schaan BD. Predictors of infection in post-coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011;26(2):190-6.
- Harrington G, Russo P et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 2004;25(6):472-6.
- Harold L. Lazar et all. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004?; 109?:1497-1502
- Bravata D et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147(10):703-16.
- Gibbons R, Fihn S. Coronary revascularization: new evidence, new challenges. Ann Intern Med. 2007;147(10):732-4.
- Nalysnyk L, Fahrbach K, Reynolds M et al. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 2003;89:767-7.
- Cakmak M, Cakmak N et al. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol 2008;24(5):375-8.
- Dumbor L, Afil A, Griffin S et al. Non-infective morbidity in diabetic patients undergoing coronary and heart valve surgery. Eur J Cardio-Thorac Surg 2009;35:255-9.
- Blasco-Colmenares E, Perl T, Guallar E et al. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med. 2009;169(8):788-96.
How to Cite This Article
K.majdoub, A.Lagziri, Y.Moutakiallah, A. Abdou, M. Bamous, A. Hatim, Assfalou,M. Raissouni, M. Ait Houssa. (2018); IMPACT OF DIABETES ON EARLY AND MIDTERM OUTCOME OF CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION., Int. J. of Adv. Res., 6 (07), 1244-1249, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/7482
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.





